Neoadjuvant serplulimab combined with chemotherapy for resectable oesophageal squamous cell carcinoma: a single-arm, phase 2 trial
- Journal:
- Nature Communications
- Published:
- Affiliations:
- 3
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| The Second Affiliated Hospital, Zhejiang University School of Medicine, China | 1.00 |